爱朋医疗 reported revenue of ¥0.15B for the period ended 2026-06-30, -6.5% year on year. Net income was ¥-0.01B, a -7.9% net margin on a 65.5% gross margin. The largest revenue line is 疼痛管理产品 at 68% of the total. Free cash flow for the period was ¥0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.15B | -6.5% |
| Gross profit | ¥0.10B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | — |
| Gross margin | 65.5% | Net margin -7.9% |
| Revenue Q/Q | +17.8% | — |
| Segment | Revenue | Share |
|---|---|---|
| 疼痛管理产品 | ¥0.10B | 67.7% |
| 鼻腔及上气道产品 | ¥0.04B | 27.6% |
| 其他产品 | ¥0.01B | 4.7% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.05B | 34.5% |
| R&D | ¥0.02B | 13.3% |
| SG&A | ¥0.09B | 60.3% |
| Tax & other | ¥-0.00B | -1.5% |
| Item | Amount |
|---|---|
| Total assets | ¥0.79B |
| Total liabilities | ¥0.13B |
| Shareholders' equity | ¥0.67B |
| Equity / assets | 84.1% |
| Operating cash flow | ¥0.01B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.01B |
| Cash conversion (OCF / net income) | 102% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
华致酒行 ・ 金马游乐 ・ 罗博特科 ・ 七彩化学 ・ 康龙化成 ・ 立华股份 ・ 上海瀚讯 ・ 锦浪科技 ・ 石药创新 ・ 每日互动 ・ 震安科技 ・ 迪普科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies